Cardioprotection by kappa-opioid receptor agonist U50488H is mediated by opioidergic regulation but not by calcium current modulation

Korean Journal of Anesthesiology

Volumn 58, Issue 2, 2010, Pages 162-168

  Chun, Kook Jin ^a   Jang, Young Ho ^a,b   Kim, June Hong ^a   Kim, Jun ^a   Park, Yong Hyun ^a  

^a Pusan National University Yangsan Hospital   (South Korea)

^b Department of Anesthesiology and Pain Medicine   (South Korea)

Author keywords

Coronary occlusion; Myocardial infarction; Opioid receptors; Reperfusion

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; BINALTORPHIMINE; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CONTROLLED STUDY; ENZYME REGULATION; HEART FUNCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART RATE; MALE; NONHUMAN; PROTEIN FUNCTION; RAT; REPERFUSION INJURY;

EID: 77953450594     PISSN: 20056419     EISSN: 20057563     Source Type: Journal    
DOI: 10.4097/kjae.2010.58.2.162     Document Type: Article

References (22)

1. Lee YC, Jang YH, Kim JM, Kim AR, Kim CJ, Kim YN. Effect of a kappa-opioid receptor agonist U50488H given at early reperfusion phase in isolated rat hearts. Korean J Anesthesiol 2008; 54: S29-34.
2. Nayler WJ, Buckley DJ, Leong J. Calcium antagonists and the "stunned" myocardium. Cardioscience 1990; 1: 61-4.
3. Liu X, Engelman RM, Wei Z, Bagchi D, Rousou JA, Nath D, et al. Attenuation of myocardial reperfusion injury by reducing intracellular calcium overloading with dihydropyridines. Biochem Pharmacol 1993; 45: 1333-41.
4. Nayler WG. Basic mechanisms involved in the protection of the ischemic myocardium. The role of calcium antagonists. Drugs 1991; 42: 21-7.
5. Steenbergen C, Fralix TA, Murphy E. Role of increased cytosolic free calcium concentration in myocardial ischemic injury. Basic Res Cardiol 1993; 88: 456-70.
6. 2+ modulation during postischemic reperfusion in rat heart. Am J Physiol 1995; 268: H100-11.
7. Wang QD, Pernow J, Sjöquist PO, Rydèn L. Pharmacological possibilities for protection against myocardial reperfusion injury. Cardiovasc Res 2002; 55: 25-37.
8. Gourine AV, Pernow J, Poputnikov DM, Sjöquist PO. Calcium antagonist clevidipine reduces myocardial reperfusion injury by a mechanism related to bradykinin and nitric oxide. J Cardiovasc Pharmacol 2002; 40: 564-70.
9. Utz J, Eckert R, Trautwein W. Inhibition of L-type calcium currents in guinea pig ventricular myocytes by the kappa-opioid agonist U50488H does not involve binding to opiate receptors. J Pharmacol Exp Ther 1995; 274: 627-33.
10. Jang Y, Xi J, Wang H, Mueller RA, Norfleet EA, Xu Z. Postconditioning prevents reperfusion injury by activating delta-opioid receptors. Anesthesiology 2008; 108: 243-50.
11. Chen Z, Li T, Zhang B. Morphine postconditioning protects against reperfusion injury in the isolated rat hearts. J Surg Res 2008; 145: 287-94.
12. Guppy LJ, Littleton JM. Damaging effects of calcium paradox are reduced in isolated hearts from ethanol-dependent rats: paradoxic effects of dihydropyridine drugs. J Cardiovasc Pharmacol 1999; 34: 765-71.
13. Tai KK, Bian CF, Wong TM. kappa-Opioid receptor stimulation increases intracellular free calcium in isolated rat ventricular myocytes. Life Sci 1992; 51: 909-13.
14. Worthington MG, Opie LH. Effects of calcium channel agonism by Bay-K-8644 on ventricular fibrillation threshold of isolated heart. Cardiovasc Drugs Ther 1992; 6: 597-604.
15. Laurent S, Girerd X, Tsoukaris-Kupfer D, Legrand M, Huchet-Brisac AM, Schmitt H, et al. Opposite central cardiovascular effects of nifedipine and BAY k 8644 in anesthetized rats. Hypertension 1987; 9: 132-8.
16. Murphy JG, Marsh JD, Smith TW. The role of calcium in ischemic myocardial injury. Circulation 1987; 75: V15-24.
17. Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 2008; 88: 581-609.
18. 2+ homeostasis. J Pharmacol Exp Ther 2005; 313: 1046-57.
19. Ferdinandy P, Appelbaum Y, Csonka C, Blasig IE, Tosaki A. Role of nitric oxide and TPEN, a potent metal chelator in ischemic and reperfused rat isolated hearts. Clin Exp Pharmacol Physiol 1998; 25: 496-502.
20. Watts JA, Norris TA, London RE, Steenbergen C, Murphy E. Effects of diltiazem on lactate, ATP, and cytosolic free calcium levels in ischemic hearts. J Cardiovasc Pharmacol 1990; 15: 44-9.
21. Bogaert MG. How do calcium channel blockers prevent cardiovascular events. Are they all alike? Drugs 1996; 52(Suppl 4): 3-7.
22. Coetzee A, Conradie S. Calcium antagonist verapamil and reperfusion injury of the heart. J Cardiothorac Vasc Anesth 2007; 21: 337-43.